<?xml version="1.0" encoding="UTF-8"?>
<p>Immunization and challenge were performed on 24 cattle (
 <xref ref-type="table" rid="t2-ijn-9-5603">Table 2</xref>). Two groups received a booster dose at 4 and 7 days postvaccination (dpv). The number of cattle and vaccine regimens are summarized in 
 <xref ref-type="table" rid="t2-ijn-9-5603">Table 2</xref>. The treatments received by the groups were: 1) Group 1 (Gr-1) was immunized by intramuscular route with 0.2 mL FMD inactivated vaccine and used as a control; 2) Group 2 (Gr-2) was immunized by intranasal route 3 times with Chi-Tre-Inactivated nanoparticles on days 1, 4 and 7; 3) Group 3 (Gr-3) was immunized by intranasal route with a double dose for one time of Chi-Tre-Inactivated nanoparticles; 4) Group 4 (Gr-4) was immunized by intranasal route 3 times with Chi-PLGA-DNA nanoparticles on days 1, 4 and 7; 5) Group 5 (Gr-5) was administered with 150 mg nanoparticles of chitosan-PLGA and trehalose by intranasal route as a negative control.
</p>
